NO894610L - Fremgangsmaate for fremstilling av terapeutisk aktive 2(1h)-kinolon-forbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 2(1h)-kinolon-forbindelser.

Info

Publication number
NO894610L
NO894610L NO89894610A NO894610A NO894610L NO 894610 L NO894610 L NO 894610L NO 89894610 A NO89894610 A NO 89894610A NO 894610 A NO894610 A NO 894610A NO 894610 L NO894610 L NO 894610L
Authority
NO
Norway
Prior art keywords
group
preparation
kinolone
compounds
procedure
Prior art date
Application number
NO89894610A
Other languages
English (en)
Norwegian (no)
Other versions
NO894610D0 (no
Inventor
Masayuki Kato
Shigetaka Nishino
Kiyotaka Ito
Hisashi Takasugi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO894610D0 publication Critical patent/NO894610D0/no
Publication of NO894610L publication Critical patent/NO894610L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
NO89894610A 1988-11-21 1989-11-20 Fremgangsmaate for fremstilling av terapeutisk aktive 2(1h)-kinolon-forbindelser. NO894610L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827189A GB8827189D0 (en) 1988-11-21 1988-11-21 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same

Publications (2)

Publication Number Publication Date
NO894610D0 NO894610D0 (no) 1989-11-20
NO894610L true NO894610L (no) 1990-05-22

Family

ID=10647207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894610A NO894610L (no) 1988-11-21 1989-11-20 Fremgangsmaate for fremstilling av terapeutisk aktive 2(1h)-kinolon-forbindelser.

Country Status (17)

Country Link
US (1) US4988698A (fr)
EP (1) EP0370381B1 (fr)
JP (1) JPH02167266A (fr)
KR (1) KR900007829A (fr)
CN (1) CN1042905A (fr)
AT (1) ATE122350T1 (fr)
AU (1) AU4454289A (fr)
CA (1) CA2003397A1 (fr)
DE (1) DE68922583T2 (fr)
DK (1) DK583089A (fr)
FI (1) FI895327A0 (fr)
GB (1) GB8827189D0 (fr)
HU (1) HUT52092A (fr)
IL (1) IL92267A0 (fr)
NO (1) NO894610L (fr)
PT (1) PT92318B (fr)
ZA (1) ZA898522B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696555B2 (ja) * 1986-07-31 1994-11-30 大塚製薬株式会社 カルボスチリル誘導体
FR2637591B1 (fr) * 1988-10-11 1992-10-23 Synthelabo Derives de quinoleinone, leur preparation et leur application en therapeutique
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals
FR2711992A1 (fr) * 1993-11-03 1995-05-12 Lipha Nouveaux dérivé hétérocycliques, procédé de préparation et composition pharmaceutique les contenant.
US5814029A (en) * 1994-11-03 1998-09-29 Daig Corporation Guiding introducer system for use in ablation and mapping procedures in the left ventricle
US5912246A (en) * 1995-02-15 1999-06-15 Pharmacia & Upjohn Company Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6251109B1 (en) * 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6013654A (en) * 1997-08-14 2000-01-11 Pharmacia & Upjohn Company Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
EP1147214B1 (fr) 1999-01-13 2011-01-05 The Research Foundation Of State University Of New York Nouveau procede d'identification d'inhibiteurs de proteines kinase
JP2002542155A (ja) * 1999-03-03 2002-12-10 メルク エンド カムパニー インコーポレーテッド プレニル蛋白トランスフェラーゼの阻害剤
EP1444204A4 (fr) * 2001-10-22 2009-11-04 Univ New York State Res Found Inhibiteurs de proteines kinases et de proteines phosphatases, methodes d'identification et methodes d'utilisation associees
US7005445B2 (en) 2001-10-22 2006-02-28 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors and methods for designing them
JP2005289816A (ja) * 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
CN1150176C (zh) 2002-05-22 2004-05-19 上海医药工业研究院 芳烷酮哌嗪衍生物及其应用
UA79309C2 (en) * 2002-09-06 2007-06-11 Janssen Pharmaceutica Nv Heterocyclic compounds
US7789877B2 (en) * 2003-07-02 2010-09-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter electrode arrangement
US8147486B2 (en) * 2003-09-22 2012-04-03 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device with flexible printed circuit
US7229437B2 (en) * 2003-09-22 2007-06-12 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device having integral traces and formed electrodes
US7234225B2 (en) 2003-09-22 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Method for manufacturing medical device having embedded traces and formed electrodes
CA2575367A1 (fr) * 2004-07-28 2006-02-23 Board Of Regents, The University Of Texas System 3-bromo-2-oxopropionate de propyle et ses derives utilises comme nouveaux agents anticancereux
WO2007014851A2 (fr) * 2005-07-29 2007-02-08 F. Hoffmann-La Roche Ag Derives de indol-3-yl-carbonyl-piperidine et piperazine
US7838542B2 (en) 2006-06-29 2010-11-23 Kinex Pharmaceuticals, Llc Bicyclic compositions and methods for modulating a kinase cascade
US7501438B2 (en) * 2006-07-07 2009-03-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
FR2925902B1 (fr) * 2008-01-02 2011-01-07 Sanofi Aventis DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
KR101477156B1 (ko) * 2010-08-25 2014-12-29 (주)네오팜 신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
WO2012173952A1 (fr) 2011-06-13 2012-12-20 Emory University Dérivés de pipérazine, compositions et utilisations
CN102633717B (zh) * 2012-03-30 2013-11-20 西南大学 N-乙酰-喹啉-2(1h)酮类化合物及其制备方法和应用
CN102875465A (zh) * 2012-09-14 2013-01-16 上海大学 7-溴异喹啉的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5883677A (ja) * 1981-11-11 1983-05-19 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
DK397387A (da) * 1986-07-31 1988-02-01 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser

Also Published As

Publication number Publication date
KR900007829A (ko) 1990-06-02
HU896035D0 (en) 1990-02-28
DK583089A (da) 1990-05-22
DE68922583T2 (de) 1995-10-05
GB8827189D0 (en) 1988-12-29
ATE122350T1 (de) 1995-05-15
US4988698A (en) 1991-01-29
DE68922583D1 (de) 1995-06-14
NO894610D0 (no) 1989-11-20
DK583089D0 (da) 1989-11-20
EP0370381A3 (fr) 1991-06-26
AU4454289A (en) 1990-05-24
EP0370381A2 (fr) 1990-05-30
EP0370381B1 (fr) 1995-05-10
IL92267A0 (en) 1990-07-26
CA2003397A1 (fr) 1990-05-21
CN1042905A (zh) 1990-06-13
PT92318B (pt) 1995-09-12
HUT52092A (en) 1990-06-28
FI895327A0 (fi) 1989-11-09
PT92318A (pt) 1990-05-31
JPH02167266A (ja) 1990-06-27
ZA898522B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
NO894610D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2(1h)-kinolon-forbindelser.
NO912805L (no) Fremgangsmaate for fremstilling av pyrazolopyridin-forbindelser.
IL101785A0 (en) Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO904134D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
FI891176A (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
NO882608L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridiner.
ES2095833T3 (es) Derivados de benzodiazepinas.
ES8704494A1 (es) Un procedimiento de obtencion de imidazoquinolinas conte- niendo otros grupos heterociclicos
IL103826A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same